Drug Profile
Cholic acid - Asklepion
Alternative Names: Cholbam; Cholic acid FGK; KolbamLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Asklepion Pharmaceuticals
- Developer Asklepion Pharmaceuticals; FGK Representative Service; Travere Therapeutics
- Class Choleretics; Cholic acids; Gallstone therapies; Small molecules
- Mechanism of Action Cholesterol 7 alpha hydroxylase inhibitors; Farnesoid X-activated receptor modulators; Sodium-bile acid cotransporter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Inborn genetic disorders; Infantile Refsum disease; Peroxisomal disorders; Zellweger syndrome